One of the biggest concerns after a life-saving organ transplant is the possibility that the immune system of the host may reject the donor organ and lead to its failure. Immuno-suppressant medicines must be taken by transplant recipients to reduce the risk of this happening. In this highly specialized pharmaceutical field, Astellas is a leading manufacturer of medicines that can help to reduce the risk of organ rejection.
Webcode:
To read an article from the print magazine online, please enter the web code below, which can be found in the magazine under the article.
